Japanese chickens are now laying an expensive cancer drug ingredient
A prohibitively expensive cancer drug could soon be much cheaper for patients thanks to "mutant" Japanese chickens, Newsweek reports.
Scientists in Japan have edited chickens' genomes to make the birds lay eggs containing a protein called Interferon, which typically costs between $250 and $900 per several micrograms when manufactured without a magic hen. The Japanese chickens, though, cut the costs: Every one to two days, the hens lay an egg containing the key ingredient to combating malignant skin cancer as well as hepatitis and multiple sclerosis.
"As early as next year, a joint research company plans to sell the drug as a research reagent at a price about half that of the conventional product," The Japan News writes. "Eventually, they hope to lower the price to less than 10 percent of the current level."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"This is a result that we hope leads to the development of cheap drugs," explained Osaka University professor Hironobu Hojo. "In the future, it will be necessary to closely examine the characteristics of the agents contained in the eggs and determine their safety as pharmaceutical products."
The success of the mutant eggs could save many lives: "Research last year found that 1 in 5 cancer patients will stop taking a life-saving drug due to an inability to pay for it," Newsweek writes.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Jeva Lange was the executive editor at TheWeek.com. She formerly served as The Week's deputy editor and culture critic. She is also a contributor to Screen Slate, and her writing has appeared in The New York Daily News, The Awl, Vice, and Gothamist, among other publications. Jeva lives in New York City. Follow her on Twitter.
-
Today's political cartoons - January 12, 2025
Cartoons Sunday's cartoons - snowed in, dangerous conditions, and more
By The Week US Published
-
5 fact-checked cartoons about Meta firing its fact checkers
Cartoons Artists take on playing chicken, information superhighway, and more
By The Week US Published
-
NCHIs: the controversy over non-crime hate incidents
The Explainer Is the policing of non-crime hate incidents an Orwellian outrage or an essential tool of modern law enforcement?
By The Week Staff Published
-
Honda and Nissan in merger talks
Speed Read The companies are currently Japan's second and third-biggest automakers, respectively
By Peter Weber, The Week US Published
-
Taylor Swift wraps up record-shattering Eras tour
Speed Read The pop star finally ended her long-running tour in Vancouver, Canada
By Peter Weber, The Week US Published
-
Drake claims illegal boosting, defamation
Speed Read The rapper accused Universal Music of boosting Kendrick Lamar's diss track and said UMG allowed him to be falsely accused of pedophilia
By Rafi Schwartz, The Week US Published
-
'Wicked' and 'Gladiator II' ignite holiday box office
Speed Read The combination of the two movies revitalized a struggling box office
By Peter Weber, The Week US Published
-
Jussie Smollet conviction overturned on appeal
Speed Read The Illinois Supreme Court overturned the actor's conviction on charges of staging a racist and homophobic attack against himself in 2019
By Peter Weber, The Week US Published
-
Quincy Jones, music icon, is dead at 91
Speed Read The legendary producer is perhaps best known as the architect behind Michael Jackson's 'Thriller'
By Peter Weber, The Week US Published
-
OJ Simpson, star athlete tried for murder, dead at 76
Speed Read The former football hero and murder suspect lost his battle with cancer
By Rafi Schwartz, The Week US Published
-
Momofuku's 'Chili Crunch' trademark uproar
Speed Read The company's attempt to own the sole rights has prompted backlash
By Rafi Schwartz, The Week US Published